ESKAYEF VS COMMISSIONER OF INCOME-TAX
2001 P T D 1496
[245 1 T R 1161
[Supreme Court of India]
Present: S. P. Bharucha and Mrs. Ruma Pal, JJ
ESKAYEF
(now known as SmithKline Beecham Pharmaceuticals (India) Ltd.)
versus
COMMISSIONER OF INCOME‑TAX
Civil Appeals Nos. 2717 with 4545 to 4547 of 1996, decided on 20/07/2000.
(Civil Appeal No. 2717 of 1996 was by certificate from the judgment and order, dated March 11, 1991 of the Karnataka High Court in I.T.R.C. No. 182 of 1985).
(a) Income‑tax‑‑‑
‑‑‑‑Businessexpenditure‑‑‑Company‑‑‑Surtax‑‑‑Not deductible‑Indian income Tax Act, 1961, S.37.
Held, (i) that the liability to pay surtax is not an admissible deduction in computing the total income.
Smith Kline and French (India) Ltd. v. CIT (1996) 219 ITR 581 (SC) fol.
(b) Income‑tax‑‑‑
‑‑‑‑Business expenditure‑‑‑Disallowance of expenditure‑‑‑Expenditure on advertisement and sales promotion‑‑‑Expenditure incurred by pharmaceutical company on distribution of free samples of prescription drugs to doctors‑- Expenditure in nature of publicity and sales promotion‑‑‑Subsection (3A) of S.37 is applicable to such expenditure‑‑‑Indian Income Tax Act, 1961, S.37(3A).
Having regard to the fact that these were prescription drugs, the target for any advertisement or publicity or sales promotion thereof could only be the doctor who would prescribe them. The object of distribution of the samples of the drugs to the doctors was to make them aware that such drugs were available in the market in relation to the cure of a particular affliction and, therefore, to persuade them to prescribe the same in appropriate cases. So' doing was tantamount to publicity and sales promotion. It fell within the scope of section 37(3A) of the Income Tax Act, 1961, and would be subject to the limitations as to allowability therein contained.
Smith Kline and French (India) Ltd. v. CIT (1992) 193 ITR 582 affirmed.
CIT v. Ampro Food Products (1995) 215 ITR 904 (AP) and CIT v. J & J Dechane Laboratories (P.) Ltd. (1996) 222 ITR 11 (AP) ref.
D.A. Dave, Senior Advocate (Ms. Pratibha M. Singh, Ms. Kavita Wadia, Ramesh Singh, Maninder Singh and M.S. Syal, Advocates with him) for Appellant.
M.L. Verma, Senior Advocate (G. Venkatesh Rao and Ms.,Sushma Suri, Advocates with him) for Respondent.
JUDGMENT
Civil Appeal No. 2717 of 1996:
S.P. BHARUCHA, J.‑‑‑The appeal relates to the assessment year 1980‑81. It is on a certificate of fitness to appeal granted by the High Curt. The certification was only in respect of one question, which reads thus:
"Whether on the facts and in the circumstances of the case, the liability to pay surtax is an admissible deduction in computing the total income?"
The answer to this question is covered against the assessee by the decision of this Court in the assessee's own case (Smith Kline and French (India) Ltd. v. CIT (1996) 219 ITR 581). The question is, accordingly answered in the negative and in favour of the Revenue.
The civil appeal is dismissed.
No order as to costs.
Civil Anneals Nos.4545 to 4547 of 1996.
These are appeals from the judgment and order of the Division Bench of the Karnataka High Court in income‑tax references. The questions that the High Court was called upon to answer read thus:
"Questions of law in I.T.R. No. 144 of 1993:
(a) Whether, on the facts and in the circumstances of the case, the liability to pay surtax is an admissible deduction in computing the total income?
(b) Whether, on the facts and in the circumstances of the case, the expenditure incurred on physician's samples is in the nature of advertisement expenditure falling within the restrictive provisions of section 37(3A) of the Income‑tax Act?
Question of law 'in I.T.R. C. No. 143 of 1993:
(a) Whether, on the facts and in the circumstances of the case, the liability to pay surtax is an admissible deduction in computing the total income?
Question of law in I.T.R. C. No. 171 of.1994:
Whether, on the facts and in the circumstances of the case, the Tribunal was right in holding that the applicant was not entitled to the deduction of surtax levied while computing the total income of the applicant
It is common ground that the questions that relate to surtax must be answered in the negative and in favour of the Revenue by reason of the judgment of this Court in the case of Smith Kline and French (India) Ltd. v. CIT (1996) 219 ITR 581. They are so answered.
The issue that is canvassed at the Bar relates to the physicians samples that the assessee, a pharmaceutical company, distributes to the medical profession. It is the assessee's case that these are all samples of prescription drugs, and we proceed upon that basis.. Learned counsel for the assessee submitted that the distribution of physicians samples to doctors did not amount to advertisement or publicity or sales promotion and, therefore, all the expenditure incurred by the appellants on such distribution was exempt, under the provisions of section 37 of the Income‑tax Act, 1961 (for short "the Act"), as expenditure incurred wholly and exclusively for the purpose of the appellants business, and not subject to the restrictions on allowability contained in subsection (3A) thereof.
The submission did not find favour with the Income‑tax Appellate Tribunal and with the High Court. The High Court, in the order under appeal, followed its earlier judgment in the case of Smith Kline and French (India) Ltd. v. CIT (1992) 193 ITR 582 (which also concerned the assessee. The High Court there had said (page 585):
"We do not think that we should discuss the principle pertaining to the interpretation of statutes referred to above in detail because the idea behind the contention is to convey that, advertisement, publicity or sales promotion should be confined to the act of media propaganda and a direct approach to the consumers by publicising the prod ct through newspaper advertisement, posters or some other similar methods. We do not think that such a limited meaning should be given to the three words. The nature of the advertisement or publicity depends upon the nature and quality of the article in question. An inducement to the public to buy a particular commodity may be formulated in a mode most suitable to the article in question.
The members of the public would not buy a drug just because it is advertised repeatedly or publicised through posters or announced on the T.V. etc. The members of the public should have confidence about the curative value of the drug and such confidence could be created mainly by the medical practitioners prescribing the said drug or when the medical practitioners give the same to patients towards treatment. The media through which the drug could get publicised and earn goodwill will be the media of prescription by, the medical practitioner. Further, the real persons who could create a market for a particular drug are the medical practitioners themselves having regard to the nature of the drug, when compared to other industrial products. A drug is not an ordinary article of consumption. It is consumed only to .get rid of some, ailment. Before the drug gets circulated, its reputation will have to be confirmed to the medical practitioners and that is why free samples are supplied to them. If the object of supplying free samples is only to find out the reaction of the medical practitioners about the efficacy or curative value of the drug, the supply of free samples would have been confined during the initial stages of production of a new drug. However, that is not the case of the assessee here. The assessee no where contends that free samples were given to the medical practi tioners only at the time when a drug is introduced for the first time.
Learned counsel for the Revenue also pointed out that the assessee in its original return of income has included these sums under the head Advertisement, publicity and sales promotion. Therefore, the assessee's first impression about the nature of the free samples was the correct approach and the assessee has properly disclosed the same under an appropriate head in the return. Subsequently, the assessee sent a letter modifying the original return of income and offered to confine the claim under this head to a part of the expenditure.
Learned counsel for the Revenue is justified in pointing out the above circumstance as an additional factor in support of the conclusion arrived at by the Appellate Tribunal.
Each of the three words advertisement, publicity and sales promotion cannot always be confined to distinct and different concepts. Some aspects of one word would naturally overlap with the meaning attributed to the other word. No doubt, in a commercial sense, the purpose of these activities is to gain goodwill and a market but the mode of achieving this object cannot be confined to the limited meaning attributed to them by learned counsel for the assessee. "
Learned counsel for the assessee submitted that the physicians' samples were distributed only to doctors and, therefore, the expenditure incurred thereon could not be said to be for advertisement or publicity or sales promotion. He submitted that the purpose of such distribution was to obtain a feedback from the medical profession as to the efficacy of the distributed drugs. As to the first point, we are entirely in agreement with the view taken in the judgment under appeal. Having regard to the fact that these are prescription drugs, the target for any advertisement or publicity or sales promotion thereof could only be the doctors who would prescribe them. The object, we have no doubt, of distribution of the samples of the drugs to the doctors is to make them aware that such drugs are available in the market in relation to the cure of a particular affliction and, therefore, to persuade them to prescribe the same in appropriate cases. So doing is, in our view, tantamount to publicity and sales promotion. Regarding the submission that the distribution of the physicians samples of the drugs is meant only for obtaining feedback from the doctors, we should have thought that the assessee would have backed it up by the production of such feedback in the form of filled up questionnaires or letters as it might have .received from doctors in the past, if any. It is an eloquent answer to the submission that there has been no such production.
Learned counsel for the assessee drew our attention to the provisions of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. Section 3 thereof prohibits the publication of any advertisement referring to any drug the terms of which suggest or are calculated to lead to the use of that drug for "(d) the diagnosis, cure, mitigation, treatment or prevention of any disease, disorder or condition specified in the Schedule, or any other disease, disorder or condition.... "Learned counsel's submission was that we should not decide in a manner which would lead to the conclusion that the assessee had advertised by means of physicians' samples, drugs contrary to the prohibition under the Drugs and Magic (Objectionable Advertisements) Act, 1954. We do not read the prohibition therein as applicable to physician's samples. What is barred thereby is publication, and that is amply clear when one refers to the definition of "advertisement" in that Act.
Learned counsel for the assessee cited the judgment of a Division Bench of the Andhra Pradesh High Court in the case of CIT v. Ampro Food Products (1995) 215 I'm 904. The judgment, substantially, takes the view the Karnataka High Court had taken in the assessee's case cited above, except that it said (page 912) "Expenditure of the nature which is essential to the running of the business‑‑‑a bare minimum to carry on the trade‑‑‑would not fall within the meaning of the three' expressions, i.e., advertisement, publicity and sales promotion. The other expenditure, incurred under any of the three heads, would be within the mischief of the provisions of sub section (3A) of section 37 of the Act and, therefore, will have to be scaled down." The judgment in Ampro Food Products' case (1995) 215 ITR 904 (AP) was followed by the Andhra Pradesh High Court in CIT v. J & J Dechane Laboratories (P.) Ltd. (1996) 222 ITR 11. This was a case that related to physician's samples. The High Court said (page 15):
"In the instant case, the assessee claimed expenditure on distribution of physicians samples under section 37 general head. In view of the principles settled by this Court in the aforesaid decision, if the expenditure falls within the bare minimum it will not be caught by subsection (3A) of section 37, but if it is of the nature which is not essential to the carrying on of the business, it will be within the net of subsection (3A). Physicians samples are necessary to ascertain the efficacy of the medicine and to introduce it in the market for circulation and it is only by this method the purpose is achieved. In such cases giving physicians samples for a reasonable period is essential to the business of manufacture arid sales of the medicine But if a particular medicine has been introduced into the market and its uses are established giving of free samples could only be as a measure of sales promotion and advertisement and would thus, be hit by subsection (3A). As in this case there is a finding of the Commissioner (Appeals) and confirmed by the Tribunal that the expenditure was incurred to test the efficacy of the drug, the expenditure would be within the ambit of bare minimum to carry on the business. For these reasons, it has to be held that the expenditure on physicians' samples distributed to doctors is outside the scope of subsection (3A) of section 37 of the Act. Therefore, the appellate authority as well as the Tribunal are right in directing the exclusion of the expenditure on free samples supplied to the doctors in working out disallowance under section 37(3A) of the Act.
We find it difficult to draw the distinction that the Andhra Pradesh High Court made between expenditure that is essential to the running of the business and other expenditure, all this expenditure being incurred for the same purpose. If all this expenditure on distribution of physicians' samples is incurred for the purposes of publicity or sales promotion, as we think it is, it falls within the scope of section 37(3A) of the Act and would be subject to the limitations as to allowability therein contained. Further, it should be noted that in the case of CIT v. J & J Dechane Laboratories (P.) Ltd. (1996) 222 ITR 11 (AP), the Commissioner of Income‑tax (Appeals) and the Tribunal had found as a fact that some expenditure had been incurred to test the efficacy of the concerned drug. There is no such finding in the case before us.
In the result, we are not persuaded to take a view other than that taken by the High Court. The question relating to physicians' samples is, therefore, answered in the affirmative and in favour of She Revenue. The appeals are dismissed with costs.
M.B.A./485/FC Reference answered.